Literature DB >> 25425436

A review of rodent models of peritoneal dialysis and its complications.

Ji Wang1, Shujun Liu, Hongyu Li, Jing Sun, Sijin Zhang, Xiaohong Xu, Yingying Liu, Yangwei Wang, Lining Miao.   

Abstract

This article reviews the available rodent models of peritoneal dialysis (PD) that have been developed over the past 20 years and the complications associated with their use. Although there are several methods used in different studies, the focus of this article is not to review or provide detailed summaries of these methods. Rather, this article reviews the most common methods of establishing a dialysis model in rodents, the assays used to observe function of the peritoneum in dialysis, and how these models are adapted to study peritonitis and peritoneal fibrosis. We compared the advantages and disadvantages of different methods, which should be helpful in studies of PD and may provide valuable data for further clinical studies.

Entities:  

Mesh:

Year:  2014        PMID: 25425436     DOI: 10.1007/s11255-014-0829-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  82 in total

1.  An experimental sclerosing encapsulating peritonitis model in mice.

Authors:  Y Ishii; T Sawada; A Shimizu; T Tojimbara; I Nakajima; S Fuchinoue; S Teraoka
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

2.  Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution.

Authors:  Roos van Westrhenen; Jan Aten; Medhanit Aberra; Cindy A M Dragt; Gregory Deira; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2005-02       Impact factor: 1.756

3.  The effects of ouabain and potassium on peritoneal fluid and solute transport characteristics.

Authors:  M S Park; E Y Lee; N S Lee; J Waniewski; B Lindholm; H B Lee
Journal:  Perit Dial Int       Date:  1998 Jul-Aug       Impact factor: 1.756

4.  Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.

Authors:  K Tanabe; Y Maeshima; K Ichinose; H Kitayama; Y Takazawa; K Hirokoshi; M Kinomura; H Sugiyama; H Makino
Journal:  Kidney Int       Date:  2006-12-27       Impact factor: 10.612

5.  Intraperitoneal infusion of glucose-based dialysate in the rat--an animal model for the study of peritoneal advanced glycation end-products formation and effect on peritoneal transport.

Authors:  E Zeltzer; O Klein; G Rashid; D Katz; Z Korzets; J Bernheim
Journal:  Perit Dial Int       Date:  2000 Nov-Dec       Impact factor: 1.756

6.  Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.

Authors:  Mohammad Zareie; Eelco D Keuning; Piet M ter Wee; Casper G Schalkwijk; Robert H J Beelen; Jacob van den Born
Journal:  Nephrol Dial Transplant       Date:  2005-11-01       Impact factor: 5.992

7.  Erythropoietin suppresses peritoneal fibrosis in rat experimental model.

Authors:  Stefania Mondello; Emanuela Mazzon; Rosanna Di Paola; Concetta Crisafulli; Domenico Italiano; Michele Buemi; Calmela Aloisi; Salvatore Cuzzocrea
Journal:  Eur J Pharmacol       Date:  2008-11-27       Impact factor: 4.432

8.  Smad7 gene transfer attenuates angiogenesis in peritoneal dialysis rats.

Authors:  Weisheng Peng; Xianrui Dou; Wenke Hao; Qiaoling Zhou; Rong Tang; Jing Nie; Hui Y Lan; Xueqing Yu
Journal:  Nephrology (Carlton)       Date:  2013-02       Impact factor: 2.506

9.  Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis.

Authors:  Yanyan Sun; Fengxin Zhu; Xueqing Yu; Jing Nie; Fengxian Huang; Xiaoyan Li; Ning Luo; Hui Yao Lan; Yongtao Wang
Journal:  Am J Nephrol       Date:  2009-02-18       Impact factor: 3.754

10.  Impact of rapamycin on peritoneal fibrosis and transport function.

Authors:  T Xu; J Y Xie; W M Wang; H Ren; N Chen
Journal:  Blood Purif       Date:  2012-08-24       Impact factor: 2.614

View more
  4 in total

1.  Early peritoneal dialysis reduces lung inflammation in mice with ischemic acute kidney injury.

Authors:  Chris Altmann; Nilesh Ahuja; Carol M Kiekhaefer; Ana Andres Hernando; Kayo Okamura; Rhea Bhargava; Jane Duplantis; Lara A Kirkbride-Romeo; Jill Huckles; Benjamin M Fox; Kashfi Kahn; Danielle Soranno; Hyo-Wook Gil; Isaac Teitelbaum; Sarah Faubel
Journal:  Kidney Int       Date:  2017-03-16       Impact factor: 10.612

2.  Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis.

Authors:  Nobuyuki Ashizawa; Taiga Miyazaki; Shinichi Abe; Takahiro Takazono; Tomomi Saijo; Yoko Obata; Shintaro Shimamura; Kazuko Yamamoto; Yoshifumi Imamura; Takehiko Koji; Tomoya Nishino; Koichi Izumikawa; Katsunori Yanagihara; Shigeru Kohno; Hiroshi Mukae
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

Review 3.  Experimental models in peritoneal dialysis (Review).

Authors:  Bo Yang; Mengmeng Wang; Xue Tong; Ghada Ankawi; Lin Sun; Hongtao Yang
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

4.  Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats.

Authors:  Filipe M O Silva; Priscila O Carvalho; Elerson C Costalonga; Rafael Pepineli; Raul C Maranhão; Irene L Noronha
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.